Navigation Links
Neuralgia Global Clinical Trials Review, H2, 2014
Date:8/5/2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Neuralgia Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256143/Neuralgia-Global-Clinical-Trials-Review-H2-2014.html

Neuralgia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Neuralgia Global Clinical Trials Review, H2, 2014" provides data on the Neuralgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuralgia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuralgia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Neuralgia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neuralgia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neuralgia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Neuralgia 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Neuralgia Therapeutics Clinical Trials 35
Prominent Drugs 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
AstraZeneca PLC 43
Clinical Trial Overview of AstraZeneca PLC 43
NeurogesX, Inc. 45
Clinical Trial Overview of NeurogesX, Inc. 45

Grunenthal GmbH 46
Clinical Trial Overview of Grunenthal GmbH 46
GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
GW Pharmaceuticals plc 48
Clinical Trial Overview of GW Pharmaceuticals plc 48
Merck & Co., Inc. 49
Clinical Trial Overview of Merck & Co., Inc. 49
Spinifex Pharmaceuticals Pty Limited 50
Clinical Trial Overview of Spinifex Pharmaceuticals Pty Limited 50
Endo International plc 51
Clinical Trial Overview of Endo International plc 51
Eli Lilly and Company 52

Clinical Trial Overview of Eli Lilly and Company 52
Clinical Trial Overview of Top Institutes / Government 53
University Hospital of Clermont-Ferrand 53
Clinical Trial Overview of University Hospital of Clermont-Ferrand 53
Lawson Health Research Institute 54
Clinical Trial Overview of Lawson Health Research Institute 54
Stanford University 55
Clinical Trial Overview of Stanford University 55
Rigshospitalet 56
Clinical Trial Overview of Rigshospitalet 56
Danish Pain Research Center 57
Clinical Trial Overview of Danish Pain Research Center 57
Leiden University Medical Center 58
Clinical Trial Overview of Leiden University Medical Center 58
Rambam Health Care Campus 59
Clinical Trial Overview of Rambam Health Care Campus 59
University of Manitoba 60
Clinical Trial Overview of University of Manitoba 60
University of California, San Francisco 61
Clinical Trial Overview of University of California, San Francisco 61

U.S. Department of Veterans Affairs 62
Clinical Trial Overview of U.S. Department of Veterans Affairs 62
Five Key Clinical Profiles 63
Appendix 161
Abbreviations 161
Definitions 161
Research Methodology 162
Secondary Research 162
About GlobalData 163
Contact Us 163
Disclaimer 163
Source 163

List of Tables

Neuralgia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Neuralgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Neuralgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Neuralgia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Neuralgia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Neuralgia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Neuralgia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Neuralgia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Neuralgia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Neuralgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Neuralgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Neuralgia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Neuralgia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Neuralgia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Neuralgia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Neuralgia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Neuralgia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Neuralgia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Neuralgia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Neuralgia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Neuralgia Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Neuralgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Neuralgia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 33
Neuralgia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Neuralgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Neuralgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 38
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 43
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2014* 45
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Grunenthal GmbH, 2014* 46
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 47
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 48

Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 49
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spinifex Pharmaceuticals Pty Limited, 2014* 50
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014* 51
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 52
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Clermont-Ferrand, 2014* 53
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014* 54
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 55
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 56
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Pain Research Center, 2014* 57
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 58
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2014* 59
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 60
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 61
Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 62

List of Figures

Neuralgia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Neuralgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Neuralgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Neuralgia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Neuralgia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Neuralgia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Neuralgia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Neuralgia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Neuralgia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Neuralgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Neuralgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Neuralgia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Neuralgia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Neuralgia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Neuralgia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21

Neuralgia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Neuralgia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Neuralgia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Neuralgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Neuralgia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 33
Neuralgia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Neuralgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35
Neuralgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 162

To order this report: Neuralgia Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256143/Neuralgia-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
2. Convergence Pharmaceuticals Announces Start of Phase II Study for Cav2.2 Selective Blocker, CNV2197944 in Pain Associated with Post-Herpetic Neuralgia
3. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
4. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
5. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
6. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
7. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
8. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
9. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
10. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
11. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... 18, 2017  Astute Medical, Inc., developer of biomarkers ... be presented at the 2017 National Kidney Foundation (NKF) ... continues through April 22. Physicians will present data on ... assess risk for acute kidney injury (AKI) during the ... Elevated levels of TIMP-2 and IGFBP-7 ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext ... of collaboration started in 2016, in which Socionext ... Brain SOINN". The companies achieved initial results in ... solution by Artificial Brain SOINN. The results will ... Big Sight, April 19-21, at booths 4505 & ...
(Date:4/18/2017)... April 18, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... of bacterial infections, will present preclinical data supporting the ... multidrug resistant (MDR) Gram-negative infections at the 27th European ... 22-25, 2017 in Vienna, Austria . ... "Our ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the Renaissance ... program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish we ... entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. Ted ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... Donna ... topics, but she has not found any of them to be very practical. She ... to slowly and easily make changes in their health. It prompted her in writing ...
(Date:4/24/2017)... ... 2017 , ... “Reflections of God’s Work”: an enlightening collection of life lessons ... creation of published author, Jerri Broglin, a survivor of great loss who gained insight ... great eye-opener for those searching for answers, as we are finding the answers that ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Life of Purpose ... of Florida. The event will be held at 7:30 pm on May 10th at ... and Drew Copeland of Sister Hazel, will support the UF Collegiate Recovery Community (UFCRC). ...
Breaking Medicine News(10 mins):